Philadelphia, PA USA

Our News on Newswise

Dr. Stanley A. Plotkin to Receive the Hamdan Award for Medical Research Excellence in the Field of Vaccines


On Dec. 16, Wistar Institute Emeritus Professor Dr. Stanley A. Plotkin receives the Hamdan Award at the Dubai International Conference for Medical Sciences.
14-Nov-2014 4:00 PM EST

The Wistar Institute Welcomes Heather Steinman, New Vice President for Business Development & Executive Director, Technology Transfer


The Wistar Institute is pleased to announce the appointment of Heather A. Steinman, Ph.D., M.B.A., as Vice President for Business Development and Executive Director, Technology Transfer, a newly created position with a pivotal leadership role in...
24-Oct-2014 11:00 AM EDT

Middle-Aged Adults Were More Susceptible to the Flu Last Year Because of a New Viral Mutation

Wistar researchers have identified a new mutation in the H1N1 influenza virus that made it easily transmitted in middle-aged adults--those who should be able to resist the viral assault--during the 2013-2014 influenza season. .
21-Oct-2014 1:00 PM EDT

The Wistar Institute Opens New $100 Million Biomedical Research Facility


The Robert and Penny Fox Tower expands Wistar's biomedical research ability with state-of-the-art labs and equipment, and enhances the Institute's culture of collaboration and 'team science.'
2-Sep-2014 4:30 PM EDT

“Rewired” Mice Show Signs of Longer Lives with Fewer Age-related Illnesses

While developing an important cancer drug, Wistar scientists discovered that mice without the TRAP-1 protein live healthier longer lives, with fewer tumors and signs of aging.
1-Aug-2014 8:55 AM EDT

Bacterial Respiratory Tract Colonization Prior to Catching the Flu May Protect Against Severe Illness

Doctors have long known that people suffering from influenza are likely to do far worse (or even die) if they get a secondary infection in their lungs or airways. Infection from pneumococcus bacteria, in particular, can lead to pneumonia or a...
11-Jul-2014 12:00 PM EDT

National Cancer Institute Recommends The Wistar Institute Receive $14.9 Million Support Grant Renewal


The Wistar Institute Cancer Center receives highest rating on the renewal of its National Cancer Institute (NCI) Cancer Center Support Grant (CCSG) as well as funding of $14.9 million over the next five years.
20-Feb-2014 10:00 AM EST

Wistar to Launch Largest Randomized Trial Aiming for an HIV Cure by Diminishing Viral Reservoir Beyond Current Therapies

Wistar’s Dr. Luis Montaner leads a Philadelphia-based clinical trial – the largest of its kind to date – focused on depleting the viral reservoir in HIV patients and potentially leading toward a cure for the disease.
13-Jan-2014 10:00 AM EST

Our YouTube Videos